RT Journal Article
SR Electronic
T1 Predictors and barriers to vaccination among older Syrian refugees in Lebanon: a multi-wave survey
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.15.22282964
DO 10.1101/2022.12.15.22282964
A1 Zeid, Berthe Abi
A1 Khoury, Tanya El
A1 Ghattas, Hala
A1 Alawieh, Marwan F.
A1 Ramadan, Zeinab
A1 Anouti, Sirine
A1 Abdulrahim, Sawsan
A1 McCall, Stephen J.
YR 2022
UL http://medrxiv.org/content/early/2022/12/16/2022.12.15.22282964.abstract
AB Background Access to vaccination is important to prevent morbidity and mortality due to COVID-19 among older Syrian refugees. This study aimed to develop an internally validated predictive model for COVID-19 vaccination amongst older Syrian refugees in Lebanon and understand barriers to vaccination.Methods This multi-wave longitudinal study was conducted through telephone interviews between September 2020 and March 2022 in Lebanon. Syrian refugees aged 50 years or older were invited to participate from a list of households that received assistance from a humanitarian organization. The outcome was self-reported COVID-19 vaccination status. Logistic regression was used to identify predictors of vaccination uptake. Validation was completed internally using bootstrapping methods.Findings Out of 2,906 participants (median[IQR] age:58[55-64]; 52.9% males), 1,235(42.5%) had received at least one dose of the COVID-19 vaccine. The main reasons for not receiving the first dose of the vaccine included being afraid of the vaccine side effects (40.1%) or not wanting the vaccine (38.1%). The main reason for not receiving the second or third dose was still waiting for a text message for an appointment (67.1% and 73.5%, respectively). Predictors of receiving at least one dose of COVID-19 vaccine included: age, sex, residence, education and intention of vaccination. After adjusting for optimisation, the final model showed moderate discrimination (c-statistic=0.605[95%CI:0.584 to 0.624]) and good calibration (c-slope=0.912[0.758 to 1.079]).Interpretation There is an ongoing need to address vaccine acceptance and uptake among older Syrian refugees, by improving deployment planning, and raising awareness campaigns about the importance of the vaccine.Funding The study was funded by ELRHA’s Research for Health in Humanitarian Crisis (R2HC) Programme. R2HC is funded by the UK Foreign, Commonwealth and Development Office (FCDO), Wellcome, and the UK National Institute for Health Research (NIHR).Evidence before the study We searched PubMed and Google Scholar for studies published up to September 29, 2022, that target COVID-19 vaccine hesitancy and uptake among older Syrian refugees in the region. We used the following combinations of keyword in our search: “COVID-19 vaccine hesitancy”, “COVID-19 vaccine uptake”, “vaccine literacy”, “vaccine acceptance”, “Syrian refugees”, “predictors”, and “education”. Previous evidence has shown that Syrian refugees have a high risk of severe morbidity and death from COVID-19 infection. Vaccine hesitancy among this vulnerable group in Lebanon is high, and there is a paucity of data available about vaccine uptake in refugee populations. In addition, older Syrian refugees have faced multiple barriers to accessing healthcare. Hence, measuring actual COVID-19 vaccine uptake and understanding the predictors influencing vaccine uptake among older Syrian refugees is critical to improving vaccination access and strategies related to COVID-19 in Lebanon.Added value of the study To our knowledge, no studies have examined predictors of COVID-19 vaccine uptake and measured the rate of vaccination among older Syrian refugees. Out of 2,906 participants, 1,235 (42.5%) received at least one dose of COVID-19 vaccine, and 806 (27.7%) received two doses of the COVID-19 vaccine. From the available data from the Ministry of Public health in Lebanon, the reported rate of vaccination among this group is low compared to the Lebanese population. In addition, this study developed a predictive model and identified five predictors of receiving at least one dose of COVID-19 vaccine among older Syrian refugees: age, sex, residence (inside or inside informal tented settlement), education and intention of vaccination.Implications of all the available evidence These findings suggest an ongoing need to address vaccine acceptance and uptake among older Syrian refugees by spreading awareness about the importance of the COVID-19 vaccine and enhancing the national system for faster vaccine coverage and response in future crises. Focusing on vaccine intention through tailored interventions and targeting hard-to-reach populations will improve vaccine uptake among Syrian refugees.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by ELRHA's Research for Health in Humanitarian Crisis (R2HC) Programme, which aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises. R2HC is funded by the UK Foreign, Commonwealth and Development Office (FCDO), Wellcome, and the UK National Institute for Health Research (NIHR). The views expressed herein should not be taken, in any way, to reflect the official opinion of the NRC or ELRHA. The funder had no participation in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the American University of Beirut Social and Behavioral Sciences Institutional Review Board [Reference: SBS-2020-0329]. Consent to participate was obtained verbally from all the participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe anonymised data can be requested upon reasonable request from NRC (nrc@nrc.no) and AUB (crph@aub.edu.lb).